Takuya Tsujino

20PUBLICATIONS
72CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Sep 29, 2026
Multiplex Immunofluorescence-defined CXCL13-associated TLS-like Niches Predict Outcome in Bladder Cancer.

|Sep 13, 2026
Integrated Analysis of HER2 Expression and ERBB2 Alterations in Bladder Cancer.

|Jul 17, 2026
A ferroptosis-suppressive state drives resistance to bladder-preserving chemoradiotherapy in muscle-invasive bladder cancer.

|May 20, 2026
Prognostic Significance of Pretreatment Blood-Based Biomarkers in Penile Cancer: A Multicenter Retrospective Study in Japan.

|Mar 31, 2026
A Two-Factor Bedside Prognostic Score Integrating Eastern Cooperative Oncology Group (ECOG) Performance Status and Aggressive Metastatic Burden in Metastatic Hormone-Sensitive Prostate Cancer.

Koichiro Kurokawa, Satoshi Yamamoto, Yasutaka Yamada

|Mar 15, 2026
The Prognostic Significance of Radiographic Progression Without PSA Progression in Patients With Metastatic Hormone-Sensitive Prostate Cancer Treated With First-Line ARPI Therapy.

Takeshi Tsutsumi, Shogo Yamazaki, Takuya Matsuda

Pageof 4

Frequent Collaborators

8 joint publications

Kazumasa Komura

5 joint publications

Kohei Taniguchi

4 joint publications

Fumihiko Urabe

4 joint publications

Takahiro Kimura